Helping to accelerate the development of novel drugs against Covid-19 disease
Thus, the current fight against Covid-19 disease heavily relies on already available drugs. Unfortunately, there is hardly any drug that fights the disease effectively. Cortisone based therapeutics are currently the ones used most frequently and most successfully. The originally promising drug Remdesivir, which has been approved for the treatment of Covid-19 for several months ago, plays a limited role in treatment, because it only works during the early phase of the disease. Therefore, there is still a high demand in developing new drugs against Covid-19 disease.
myriamed can help to accelerate the development of these drugs. With its products and services myriamed supports pharmaceutical and biotech companies from early preclinical to clinical stages of drug development to accelerate the clinical translation of novel safe and efficacious therapeutics.
myriamed has unique expertise in research and development of human induced pluripotent stem cells (iPSC), including genome edited lines, and in the controlling of their fate as to the differentiation into defined cellular lineages and tissues (published for example in Tiburcy et al. 2017 and Long et al. 2018). The myriamed product portfolio is constantly evolving and based on a comprehensive IP portfolio to offer its know-how and associated services in drug development.
To learn more about myriamed’s products and services please contact us on:
Tel.: +49 551 28878-170
myriamed – the drug development accelerator
Separating the pharmacological wheat from the chaff is the primary goal of myriamed. Our proprietary human cell and engineered tissue models allow for the simulation of health and disease in the dish. Our platform technologies find broad applications in early stages of drug discovery and refinement of the most promising therapeutic candidates.
The availability of human cell and tissue models is transforming preclinical drug development. Applications range from early stages of lead discovery to advanced individualized phenotypic screens to shape a promising therapeutic candidate. myriamed offers a broad portfolio of highly standardized services as well as custom-made solutions to accelerate drug development.
At myriamed we focus on heart and skeletal muscle as well as on neuronal organoids. Our myrCell and myrTissue platforms define wanted and unwanted drug effects in a unique human context. myrScreen combines our expertise in phenotypic drug screens and enables deep phenotyping of drug effects on healthy or diseased human heart and skeletal muscle as well as on neuronal organoids.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Helping to accelerate the development of novel drugs against Covid-19 disease here
News-ID: 2201464 • Views: 248
More Releases from myriamed GmbH
myriamed has joined Science Exchange
Science Exchange, the leading SaaS-enabled marketplace platform for outsourced R&D services, has partnered with myriamed. Visit myriamed’s profile to inquire about our services or request a quote. There are no additional contracts required if you request on Science Exchange and you can order immediately. Please visit our profile here: http://bit.ly/myriamed_Science_Exchange About myriamed: myriamed has unique expertise in research and development of human induced pluripotent stem cells (iPSC), including genome edited lines, and
myriamed is now a member of the Network for Pharma Solutions
We are proud to announce that myriamed is now a member of the Network for Pharma Solutions (NetPhaSol). NetPhaSol is a cooperation network focusing on drug discovery & development. It serves as a platform for research, development and marketing of new products, technologies and services in drug development. About myriamed: myriamed has unique expertise in research and development of human induced pluripotent stem cells (iPSC), including genome edited lines, and in
myriamed’s myrPlates are now also available from ZAGENO
We are proud to announce that myriamed’s myrPlates are now also available in the ZAGENO life science, e-commerce marketplace. myrPlates can be used for the generation of engineered human tissues. By parallel culture of up to 48 tissues in one myrPlate, e.g. contractile heart muscles or skeletal muscles can be obtained to serve numerous applications, such as drug screening and disease modelling. About myriamed: myriamed has unique expertise in research and development
Generation of Engineered Human Myocardium using myriamed myrPlates
In STAR Protocols Tibury et al. describe a robust method for the generation of engineered human myocardium (EHM) from pluripotent stem cells (PSCs) in 48 well myriamed myrPlates under defined, serum-free conditions (DOI: 10.1016/j.xpro.2020.100032). By parallel culture of up to 48 EHM in one myrPlate, contractile heart muscle can be obtained to serve numerous applications, such as drug screening and disease modelling, which are also offered by myriamed. The described protocol has
More Releases for Helping
A helping (Sens)Hand
How smart technology can help with manual load handling Due to mechanization and automation the amount of physical load work has been progressively reduced. Yet for those working in intralogistics, the manual handling of material is still very much part of the job. Partners in the “SensHand” project, funded by the German Federal Ministry of Education and Research (BMBF), have developed a prototype glove designed to help pickers. As
Helperschain: People Helping People
Helperschain some would say is a ponzi scheme, but we do not think we are. Helperschain is a membership scheme that believes in the ability of group financial home help. We assume that if all members who we call chainers hook their own chain to our existing long chain of chainers we are able to carry on growing and keep helping each other. Our slogans is " People helping People",
Helping Local Businesses Stay Clean
Eastern District Michigan businesses require professional cleaning services. The very reason why- Allen Maintenance Corporation, is interested in building business alliances, with local businesses. After all, one of the main concerns during the winter months, is the spread of cold viruses and Influenza germs, throughout the State of Michigan. In fact, each week, the Michigan Department of Community Health, reports on the number of people contracting the flu. And during both
Helping San Myo
A twelve year-old from Myanmar receives a leg prosthesis from Ottobock – Foundation covers costs San Myo from Myanmar is a bright and happy boy. Though the twelve year-old was born without the lower half of his left leg, the handicap doesn't keep him from playing football with friends. In order to help him walk, his father cobbled together a prosthesis using an old drain pipe. At the Ottobock facilities in
Exhibition Stand Designers Helping Creativity
Manchester-based exhibition stand designers Astro Exhibitions have come up with an innovative way of using their surplus building materials: donating them to a local high school for use in design and technology lessons. Exhibition stand designers Astro Exhibitions are using their left-over building materials to help the community. Students at New Mills School Business and Enterprise College in High Peak, will now be able to undertake more varied and challenging projects
A Helping Hand for Christmas
This year again, ConVista tries to provide the feeling of having helped to its customers. After the success in donating for the good cause instead of buying Christmas presents, ConVista decided to repeat this activity in 2010. The last time the IT consultancy supported the project of the African organization 'Food and Trees for Africa' (www.trees.co.za). With this donation, ConVista took care of a Permaculture Project at the Khayelitsha Special School